Long-term supply of Gleevec imatinib in India 13621079267

) , ) Product unit: box
, ) b ) , ) Approval number:
, ) b ) , ) Product remarks: This product is a prescription drug
, ) b ) , ) Manufacturer:
, ) b ) , ) Market price: ￥.yuan
, ) b , ) b ) , ) [Commodity name] Dashina
, ) b , ) b ) , ) [Common name] Nilotinib capsule
, ) b , ) b ) , ) [English name] C
, ) b , ) b ) , ) [Chinese Pinyin]
, ) b , ) b ) , ) [Main ingredient] The active ingredient of this product is nilotinib.
, ) b , ) b ) , ) [Characteristics] This product is a capsule, the content is white to yellow powder.
, ) b , ) b ) , ) [Indications] For chronic myeloid leukemia (+C) with Philadelphia chromosome positive that is resistant or intolerant to previous treatments (including imatinib) Adult patients in early or accelerated stages.
, ) b , ) b ) , ) [Usage and Dosage] Follow the doctor’s advice.
, ) b , ) b ) , ) [Special dosage recommendations]
, ) b ) , ) Children and Adolescents There are no clinical studies in children and adolescents. Therefore, it is not recommended for the treatment of patients younger than 10 years old.
, ) b ) , ) Elderly patients No special dose adjustment is required for patients over 10 years old.
, ) b ) , ) Patients with renal impairment No clinical studies have been conducted in patients with renal impairment.
, ) b ) , ) Only a small part of this product and its metabolites are excreted by the kidneys, so patients with renal insufficiency are not expected to experience a decrease in overall clearance. No dose adjustment is required in patients with renal impairment.
, ) b , ) b ) , ) 【Contraindications】
, ) b ) , ) It is prohibited for those who are allergic to the active substance or any excipient component of this product.
, ) b ) , ) It is contraindicated in patients with hypokalemia, hypomagnesemia or long syndrome.
, ) b